Focusing on overdiagnosis as a driver of too much medicine
暂无分享,去创建一个
[1] Carl Heneghan,et al. Overdiagnosis: what it is and what it isn’t , 2018, BMJ Evidence-Based Medicine.
[2] L. Esserman,et al. Use of Molecular Tools to Identify Patients With Indolent Breast Cancers With Ultralow Risk Over 2 Decades , 2017, JAMA oncology.
[3] J. Brodersen. How to conduct research on overdiagnosis. A keynote paper from the EGPRN May 2016, Tel Aviv , 2017, The European journal of general practice.
[4] L. Esserman,et al. Population-based screening for cancer: hope and hype , 2016, Nature Reviews Clinical Oncology.
[5] W. Rogers,et al. Casting the net too wide on overdiagnosis: benefits, burdens and non-harmful disease , 2016, Journal of Medical Ethics.
[6] Martin Eklund,et al. Prostate cancer screening in men aged 50-69 years (STHLM3): a prospective population-based diagnostic study. , 2015, The Lancet. Oncology.
[7] P. Bossuyt,et al. Assessment of changes to screening programmes: why randomisation is important , 2015, BMJ : British Medical Journal.
[8] W. Rogers,et al. The challenge of overdiagnosis begins with its definition , 2015, BMJ : British Medical Journal.
[9] Len Lichtenfeld,et al. Overdiagnosed: Making People Sick in Pursuit of Health , 2011 .
[10] J. Gray,et al. Screening: Evidence and Practice , 2019 .